Evidence-based articles for the informed patient and caregiver - bridging the gap between PubMed abstracts and actionable knowledge. No false hope, no despair. Clear-eyed precision.
Your first neuro-oncology appointment covers enormous ground in a short time. These are the questions that help you understand your molecular profile, weigh your treatment options, and decide whether to seek a second opinion before starting.
When glioblastoma comes back, re-irradiation is one of the salvage options your team may consider. This guide explains who is eligible, what the risks are, and how international patients can access specialist radiation centers.
Proton therapy and standard photon radiation (IMRT) both target glioblastoma, but they use different physics with potentially different outcomes. New Phase II randomized trial data is shifting how radiation oncologists weigh the choice - and your tumor location, molecular profile, and access to a proton center all matter.
Eating well during GBM treatment is harder than it sounds - but what you eat shapes how well your body tolerates chemotherapy and radiation. Here is what current research shows about calorie targets, the ketogenic diet, supplements, and what to avoid.
Getting a second opinion for glioblastoma is not a sign of distrust - it is a standard part of high-quality neuro-oncology care. This article explains the five key moments when a second opinion delivers the clearest value, and how to get one without losing treatment time.
GBM treatment costs differ dramatically depending on where you receive care. This article breaks down what patients and families actually pay in the USA, UK, and India - with sourced figures, coverage gaps, and practical guidance for international patients weighing their options.
Laser interstitial thermal therapy (LITT) uses MRI-guided heat to destroy recurrent glioblastoma tissue through a small skull opening. This guide covers who qualifies for the procedure, what the survival data show, and how to access LITT at a specialist center internationally.
The Stupp protocol is the standard post-surgery treatment for newly diagnosed glioblastoma. This article explains what each phase actually involves - concurrent chemoradiation, adjuvant temozolomide, and how your molecular profile shapes what the protocol means for you.
Moving to a new hospital or country while in active GBM treatment is possible if you prepare the right records and coordinate between teams. This guide covers when to transfer, what to gather, and how to avoid treatment gaps.
FoundationOne CDx, Tempus xT, and Guardant360 CDx each approach glioblastoma testing differently - and none of them includes MGMT methylation. Here is what each platform actually measures, where each falls short, and how to decide which one to order.